You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 130 No. 3, March 1994 TABLE OF CONTENTS
  Archives
  •  Online Features
  Observations
 This Article
 •References
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citing articles on HighWire
 •Citing articles on Web of Science (15)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

A Novel Immune-Mediated Subepidermal Bullous Dermatosis Characterized by IgG Autoantibodies to a Lower Lamina Lucida Component

Lawrence S. Chan, MD; Kevin D. Cooper, MD

Arch Dermatol. 1994;130(3):343-347.


Abstract

Background
Immune-mediated subepidermal bullous dermatoses characterized by in vivo—bound linear IgG deposition at the cutaneous basement membrane zone include bullous pemphigoid, ocular cicatricial pemphigoid, anti—bullous pemphigoid antigen mucosal pemphigoid, anti—epiligrin mucosal pemphigoid, epidermolysis bullosa acquisita, and the bullous eruption of systemic lupus erythematosus. In this article, we describe a novel IgG-mediated bullous dermatosis.

Observations
Clinically, a unique nonscarring dermatosis was characterized by the sudden onset of extensive bullae and erosions on mucous membrane and skin, resembling toxic epidermal necrolysis or pemphigus vulgaris. Histologically, the patient's skin lesion demonstrated neutrophilic papillary dermal infiltration and subepidermal blister formation, resembling dermatitis herpetiformis. Immunopathologically, there was linear IgG and C3 deposition at the skin basement membrane zone. The patient responded well to prednisone and azathioprine immunosuppression and has achieved a lasting remission without further therapy. Further immunologic investigations revealed that this unique dermatosis is distinct from all other known IgG-mediated subepidermal bullous dermatoses.

Conclusions
This novel deep lamina lucida pemphigoid can be distinctly termed anti—p105 pemphigoid on the basis of antigenic specificity of the autoantibodies. Although this novel dermatosis resembles toxic epidermal necrolysis clinically, prudent use of diagnostic immunofluorescence studies can clearly delineate its immunologic nature. Prompt recognition of this unique dermatosis and timely initiation of appropriate immunosuppressive therapy could be life-saving for those patients suffering from this dermatosis.

(Arch Dermatol. 1994;130:343-347)



Author Affiliations

From the Immunodermatology Unit, Department of Dermatology, University of Michigan School of Medicine, Ann Arbor (Drs Chan and Cooper), and the Department of Dermatology, Wayne State University School of Medicine, Detroit, Mich (Dr Chan). Dr Chan is now with the Department of Dermatology, Northwestern University Medical School, Chicago, Ill.



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Kinetics and Specificity of Fas Ligand Induction in Toxic Epidermal Necrolysis
Chang et al.
Arch Dermatol 2004;140:242-244.
FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1994 American Medical Association. All Rights Reserved.